Works matching IS 17591961 AND DT 2025 AND VI 16 AND IP 1

Results: 13

A thank you note to our reviewers.

Published in:: Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 84, doi. 10.1111/cen3.12832
Publication type:: Article

Muscle magnetic resonance imaging findings in patients with idiopathic inflammatory myopathies.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 72, doi. 10.1111/cen3.12831

By:

Hamano, Tadanori;
Kamisawa, Tomoko;
Sanada, Sayaka;
Hayashi, Kouji

Publication type:

Article

Interferons in myositis: Pathogenesis and therapy.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 64, doi. 10.1111/cen3.12827

By:

Tawara, Nozomu

Publication type:

Article

Unmasking the muscle mysteries: Cutting‐edge insights into inflammatory myopathies.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 42, doi. 10.1111/cen3.12826

By:

Yamashita, Satoshi

Publication type:

Article

Update on pathology of inflammatory myopathy.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 55, doi. 10.1111/cen3.12824

By:

Uruha, Akinori;
Uruha, Satoko

Publication type:

Article

Myositis‐specific/associated autoantibodies as diagnostic keys and disease drivers.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 44, doi. 10.1111/cen3.12819

By:

Yamashita, Satoshi

Publication type:

Article

Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 6, doi. 10.1111/cen3.12809

By:

Fujimoto, Takeshi;
Maeda, Yasuhiro

Publication type:

Article

Response to: Eculizumab use throughout pregnancy in two patients with aquaporin‐4‐positive neuromyelitis optica spectrum disorder.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 4, doi. 10.1111/cen3.12807

By:

Kister, Ilya;
Wilson, Alla

Publication type:

Article

Successful treatment with plasmapheresis of severe Bickerstaff brainstem encephalitis with high cerebrospinal fluid CXCL‐10 levels after COVID‐19 infection: A case report.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 30, doi. 10.1111/cen3.12806

By:

Iijima, Naoki;
Sakurai, Kenzo;
Ko, Riyoko;
Isahaya, Kenji;
Yamano, Yoshihisa

Publication type:

Article

Longitudinal imaging for monitoring disease activity in late‐onset Rasmussen's encephalitis during multimodal rehabilitation and immune therapy.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 35, doi. 10.1111/cen3.12805

By:

Adam, Lucas C.;
Gilly, Lana;
Mueller, Joerg;
Wissel, Joerg;
Kivi, Anatol

Publication type:

Article

Th17 pathway‐related immune signatures in the pathobiology of myasthenia gravis: Integrating the roles of regulatory/effector cytokines and transcription factors.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 7, doi. 10.1111/cen3.12804

By:

Varghese, Nibu;
Nagappa, Madhu;
Sreenivas, Nikhitha;
Dey, Saikat;
Mullapudi, Thrinath;
Kuniyil, Anagha Pettututhazhe;
Shivaram, Sumanth;
Seshagiri, Doniparthi V.;
Nair, Binu Valsalakumari Sreekumaran;
Debnath, Monojit

Publication type:

Article

Issue Information.

Published in:: Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 1, doi. 10.1111/cen3.12797
Publication type:: Article

Intensity of subarachnoid space inflammation corresponds to the evolution of vessel wall remodeling during the acute and chronic phases of bacterial meningitis.

Published in:

Clinical & Experimental Neuroimmunology, 2025, v. 16, n. 1, p. 19, doi. 10.1111/cen3.12794

By:

Kumar, Vivig Shantha;
Kumar, Vignarth Shantha;
Kumar, Ruthvik Thaghalli Sunil

Publication type:

Article